Article metrics

Download PDFPDF
OP0078 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, is Associated with Long-Term (52-WEEK) Improvement in Measures of Disease Activity in Patients with Psoriatic Arthritis: Results from 3 Phase 3, Randomized, Controlled Trials

 

Online download statistics by month:

Online download statistics by month: June 2014 to March 2024

AbstractFullPdf
Jun 2014601
Jul 20141300
Aug 20141500
Sep 2014601
Oct 20142302
Nov 2014701
Dec 2014503
Jan 2015300
Feb 2015600
Mar 20151001
Apr 2015300
May 2015902
Jun 2015301
Jul 2015201
Aug 2015700
Sep 20151601
Oct 2015500
Nov 2015800
Dec 20151001
Jan 2016600
Feb 2016800
Mar 20161103
Apr 20161102
May 2016701
Jun 2016801
Jul 20161000
Aug 2016500
Sep 20161202
Oct 20161903
Nov 2016501
Dec 20161100
Jan 20171001
Feb 2017900
Mar 20171801
Apr 20171503
May 20171201
Jun 2017801
Jul 2017800
Aug 2017600
Sep 20171201
Oct 2017200
Nov 20171000
Dec 20171600
Jan 20181000
Feb 2018801
Mar 20181800
Apr 2018800
May 20184401
Jun 20181000
Jul 2018800
Aug 20181000
Sep 2018800
Oct 20183200
Nov 20181000
Jan 2019800
Feb 2019801
Mar 2019400
Apr 20191200
May 2019800
Jun 2019200
Aug 2019200
Oct 2019200
Dec 2019400
Feb 2020200
Mar 2020600
Apr 20201201
May 2020400
Jun 2020200
Jul 2020200
Aug 2020400
Sep 20201000
Oct 2020400
Nov 2020600
Dec 2020400
Feb 2021200
Aug 2021101
Oct 2021600
Nov 2021100
Dec 2021800
Feb 2022800
Mar 20221001
Apr 20221100
May 2022400
Jun 2022200
Jul 20221600
Aug 2022400
Sep 2022400
Nov 2022800
Dec 20221002
Jan 2023400
Feb 2023200
Mar 2023200
May 2023400
Jul 2023400
Aug 2023200
Sep 20231200
Oct 2023400
Nov 2023400
Dec 2023800
Jan 2024400
Mar 2024200
Total815044